| P50 | author | Rebecca Mercieca-Bebber | Q46121585 |
| | P Holch | Q56850327 |
| P2093 | author name string | Michael J Palmer | |
| | Melanie Calvert | |
| | Madeleine T King | |
| | Lori McLeod | |
| | Michael Brundage | |
| | International Society for Quality of Life Research (ISOQOL) Best Practice for PROs—Reporting Taskforce | |
| | Julie Rouette | |
| P2860 | cites work | CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials | Q24614759 |
| | Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision making | Q26852751 |
| | Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review. | Q31108599 |
| | Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review | Q34495688 |
| | Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials | Q36584771 |
| | Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer | Q36910156 |
| | Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers | Q37812571 |
| | Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards | Q38044290 |
| | Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension | Q38084855 |
| | Reducing waste from incomplete or unusable reports of biomedical research | Q38177450 |
| | Patient-reported outcomes in randomised controlled trials of gynaecological cancers: investigating methodological quality and impact on clinical decision-making | Q38211577 |
| | The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: a systematic review | Q38230773 |
| | Randomized controlled trials in adult traumatic brain injury: a review of compliance to CONSORT statement | Q38286580 |
| | Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development | Q38602994 |
| | Has the quality of reporting of randomized controlled trials in thoracic surgery improved? | Q38616785 |
| | Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: A systematic review of completeness of reporting and impact on interpretation | Q38724806 |
| | Patient reported outcomes in randomized controlled cancer trials in advanced disease: a structured literature review | Q38767126 |
| | What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models | Q40505322 |
| | Inclusion of patient-reported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov (2007-2013). | Q41036982 |
| | Risk of bias versus quality assessment of randomised controlled trials: cross sectional study | Q42081186 |
| | The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice | Q42862858 |
| | Integrating health-related quality of life findings from randomized clinical trials into practice: an international study of oncologists' perspectives | Q44542767 |
| | Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy. | Q48061245 |
| P433 | issue | 6 | |
| P304 | page(s) | 1427-1437 | |
| P577 | publication date | 2017-02-07 | |
| P1433 | published in | Quality of Life Research | Q15749950 |
| P1476 | title | Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension | |
| P478 | volume | 26 | |